Teleflex orporated
Open
$127.83
Prev. Close
$127.84
High
$128.09
Low
$127.74
Market Snapshot
$5.65B
-5.6
1.45
$2.69B
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Recently from Cashu
Teleflex's BIOMAG I Study Shows Promising Safety Data for Freesolve Resorbable Scaffold Technology
Teleflex Incorporated (Ticker: TFX) presents encouraging four-year follow-up data from its pioneering BIOMAG I study at the EuroPCR conference, showcasing the continued safety of its groundbreaking Fr…
Teleflex Showcases Innovative Urology Solutions with Positive Clinical Results at Major Medical Congresses
Teleflex Incorporated (Ticker: TFX) focuses on advancing patient care through innovative solutions in urology. Recently, the company showcases impressive clinical results for its Interventional Urolog…
Teleflex Shows Resilience and Growth Following Vascular Intervention Acquisition in Earnings Report
Teleflex Incorporated (Ticker: TFX) demonstrates resilience and growth in its latest quarterly earnings report, showcasing the impact of its recent acquisition of the Vascular Intervention business. S…
Teleflex Under Pressure to Improve Shareholder Engagement Amid Growing Investor Demands
Teleflex Under Pressure to Enhance Shareholder Engagement Teleflex Incorporated finds itself at a crucial juncture as Irenic Capital, a shareholder with a 2% stake in the company, advocates for increa…